Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells

Synthetic glucocorticoids (GC) form a crucial first-line treatment for childhood acute lymphoblastic leukemia (ALL). However prolonged GC therapy frequently leads to GC-resistance with an unclear molecular mechanism. 11β-hydroxysteroid dehydrogenase (11β-HSD) 2 inactivates GCs within cells. Here, we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sai, Shuji, Nakagawa, Yuichi, Yamaguchi, Rie, Suzuki, Masako, Sakaguchi, Kimiyoshi, Okada, Shuichi, Seckl, Jonathan R., Ohzeki, Takehiko, Chapman, Karen E.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977040/
https://ncbi.nlm.nih.gov/pubmed/21794917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2011.07.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars